Vitamin Deficiency Treatment Market Size, Share, Growth Report 2030

Global Vitamin Deficiency Treatment Market: Size

The Global Vitamin Deficiency Treatment market is set for a rapid growth over the forecast period. In terms of revenue, the global vitamin deficiency treatment market size was worth around USD 5,470.7 Million in 2019 and is expected to reach USD 8,705.2 Million by 2026, growing at a CAGR of 6.86%.

Request Free Sample

Global Vitamin Deficiency Treatment Market: Overview

Vitamin deficiencies continue to pose enormous threat to the general well-being of worldwide population. Vitamin deficiencies can lead to nausea, mental confusion, irritability, depression, muscle weakness, and constipation, among others. Vitamin B12 deficiencies have been increasingly reported among athletes, individuals with high alcohol intake, and women who frequently use birth control pills. In the present situation, the market for vitamin deficiency treatment is highly on demand and includes mainly a combination of vitamin B6 and synergistic B vitamins. Vitamin B12 deficiencies have often been blinded or misdiagnosed in clinical practices around the world for several decades. However, current trends suggest that diagnosis, detection, and vitamin deficiency treatment continue to progress at an amazing speed.

Global Vitamin Deficiency Treatment Market: Growth Factors

The healthcare industry is increasingly finding new ways to overcome the burden of vitamin deficiency-related issues. As the number of people suffering from vitamin deficiencies continues to rise at an alarming pace worldwide, over the past couple of decades, vitamin deficiency therapies have gained a lot of interest. Increasing prevalence of patients with chronic or acute disorders, an increase in the amount of research and development projects, and the demand for vitamin B and vitamin D complex, due to health benefits are some of the key factors that are anticipated to affect the growth of the vitamin deficiency treatment market in the near future.

A significant number of research projects are currently focused on tackling health problems and risks associated with nutritional deficiencies. In the past few years, vitamin D testing and treatment have seen considerable progress. Protocols related to the treatment of different vitamin deficiencies continue to change due to various researches. As vitamin D deficiency proceeds to emerge as a global challenge, tackling vitamin D deficiency will require vigorous public health interventions, involving vitamin D food fortification, in addition to vitamin deficiency treatment.

The growth in the global geriatric population is expected to boost demand for vitamins and other dietary supplements at a rapid pace in the coming years. The rise in the geriatric population directly affects the supply for vitamins, mainly because of the higher vulnerability of this population to different diseases. Many developed countries have a growing geriatric population. As per WHO, the geriatric population is projected to grow rapidly in developed economies such as the United States, the United Kingdom and Japan.

Impact due to the outbreak of COVID-19

The world is currently in the midst of the coronavirus disease (COVID-19) epidemic caused by the SARS-CoV-2 virus. The virus has evolved to allow human-to-human spread, this infection can cause dry cough, fever, respiratory distress syndrome, fatigue, serious pneumonia, and death in some cases. COVID-19 affects the immune system by causing a systemic inflammatory reaction or cytokine release syndrome. Individuals affected with COVID-19 showed a high level of pro-inflammatory chemokines and cytokines There are presently no effective viral anti-SARS-CoV-2 drugs or vaccines available. COVID-19, has unfairly targeted the elderly population, both directly and through a number of significant age-related comorbidities. Nutrition is undoubtedly a key determinant of the maintenance of good health. Key nutritional ingredients such as vitamins C, D, E, selenium, zinc, and omega-3 fatty acids have well developed immunomodulatory effects and are beneficial for infectious diseases. Also, some of these nutrients have been shown to have a potential role in COVID-19 management.

Global Vitamin Deficiency Treatment Market: Segmentation

Researchers are increasingly trying to explore the potential solutions to tackle muscle weakness among the elderly population affected by vitamin D deficiency. The prevalence of vitamin D deficiency has observed massive growth over the last few years, which has necessitated a demand for supplementation of 800 IU vitamin D. In most cases, vitamin D is primarily administered in the form of cholecalciferol. The value for cholecalciferol is expected to increase in the coming years, as it is proven safe for elderly people. The demand for vitamin B complex supplements is expected to remain the highest among all other types of products followed by vitamin C and vitamin D supplements.

By route of administration, the market is segmented into the oral and parenteral route of administration. The oral route of administration is estimated to hold the largest share and the highest CAGR in the forecast period. This can be due to ease of administration, improved pharmacokinetic and pharmacodynamic operation, decreased toxicity, increased patient compliance, and growth in preference for the oral route.

Vitamin Deficiency Treatment Market: Report Scope

Global Vitamin Deficiency Treatment Market: Regional Analysis

By Geography, the vitamin deficiency treatment market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

Vitamin D deficiency is widespread in Asia Pacific, especially in South and South East Asia. Rickets (soft bone deformity) are very common in China and it is the result of low vitamin D intake. Moreover, an increase in income levels and a substantial consumer demand for nutritionally rich products are expected to provide exciting outcomes for the expansion and development of functional food and beverage products in the region, which, in turn, will lead to an increase in the intake of vitamin-infused products and thus boosting market growth.

India and China are two of the most favorable markets for vitamin D producers to expand due to increasing demand for fortified food products, animal feed, and easy availability of raw materials. It has become a major destination for vitamin D supplement manufacturers and pharmaceutical companies, such as Alkem Laboratories, Abbott Laboratories, Cadila Pharmaceuticals, and Sanofi S.A.

Global Vitamin Deficiency Treatment Market: Competitive Players

The major players in the global vitamin deficiency treatment market include

• Merck & Co. Inc.
• Cipla Inc.
• Sun Pharmaceutical Industries Ltd
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Mankind Pharma
• Dabur International Limited
• Sandoz International GmbH
• Pharmavite LLC.
• Himalaya Wellness
• BASF SE
• Reckitt Benckiser Group plc
• Glanbia plc
• Zhejiang Garden Biochemical High-Tech Co. Ltd
• DSM 

The report segment of global vitamin deficiency treatment market are as follows:

By Product

• Single Vitamin Therapies
• OTC Multivitamin Therapies
• Vitamin A Supplements
• Vitamin B Supplements
• Vitamin C Supplements
• Vitamin D Supplements
• Others

By Route of Administration

• Oral
• Parenteral

By Distribution Channel 

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa